Learn more about our upcoming Galas and Signature Events Learn More
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
The New England Journal of Medicine recently published an article focused on indoor tanning, written by scientific advisor to the MRF and chair of the department of dermato...
Contact: Berna Diehl Jones Public Affairs (202) 591-4045 Berna@JonesPA.com HILLSBOROUGH, N.J.—As summertime comes to a close, many families have left behind long, hot...
Although the last time a new drug was approved for metastatic melanoma was over a decade ago, recent advances offer new hope for patients. Two drugs, ipilimumab and P...
USA TODAY and NBC News report on results from a study highlighting a promising new therapy for metastatic melanoma. The new research, published in the New England Jou...
Earlier this week, pharmaceutical company Bristol-Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has granted a priority review for Ipilimumab, an i...
HILLSBOROUGH, N.J.—The recent debut of “The Big C” on Showtime has placed some of Hollywood’s spotlight on melanoma, the deadliest form of skin canc...
The Melanoma Research Foundation is proud to announce new research funding opportunities for medical students. Approximately five research grants will be awarded, all...
The Melanoma Research Foundation (MRF) has partnered with UVSunSense™ to promote sun safety. The UVSunSense™ wristband has a special coating&nb...
The Melanoma Research Foundation recently launched a public service announcement (PSA) to support efforts to find a cure for melanoma. The PSA features MaryAnn, who be...
-Tan tax in health care legislation begins July 1- HILLSBOROUGH, N.J.—July 1 marks the beginning of a new 10 percent federal tax instituted on indoor tanning se...
The Melanoma Research Foundation hosted a meeting on June 7 to coincide with the American Society of Clinical Oncology’s (ASCO) annual meeting in Chicago to discuss t...
Dr. Lynn Schuchter, chief of hematology/oncology at the University of Pennsylvania Abramson Cancer Center and co-chair of the MRF’s scientific advisory committee, spo...
